Get the Stockscreener App
26.37
4.19%
1.06
After Hours:
26.36
-0.01
-0.04%
Claritev Corp stock is traded at $26.37, with a volume of 49,487.
It is up +4.19% in the last 24 hours and up +51.03% over the past month.
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The company's focus is on being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
See More
Previous Close:
$25.31
Open:
$25.42
24h Volume:
49,487
Relative Volume:
0.28
Market Cap:
$447.42M
Revenue:
$965.41M
Net Income/Loss:
$-284.28M
P/E Ratio:
-1.5246
EPS:
-17.2969
Net Cash Flow:
$-12.28M
1W Performance:
+12.26%
1M Performance:
+51.03%
6M Performance:
-59.43%
1Y Performance:
+23.40%
1-Day Range:
$25.17
$26.37
1-Week Range:
$22.51
$27.05
52-Week Range:
$12.04
$74.07
Claritev Corp Stock (CTEV) Company Profile
Name
Claritev Corp
Sector
Industry
Phone
212-780-2000
Address
7900 TYSONS ONE PLACE, MCLEAN
Compare CTEV vs VEEV, BTSG, TEM, HQY, DOCS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CTEV
Claritev Corp
|
26.37 | 429.43M | 965.41M | -284.28M | -12.28M | -17.30 |
VEEV
Veeva Systems Inc
|
171.19 | 27.80B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
51.44 | 10.38B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
54.07 | 10.01B | 1.27B | -245.03M | -245.36M | -1.4071 |
HQY
Healthequity Inc
|
82.63 | 6.94B | 1.31B | 215.20M | 408.32M | 2.4627 |
DOCS
Doximity Inc
|
25.77 | 4.60B | 637.78M | 239.40M | 307.21M | 1.1909 |
Claritev Corp Stock (CTEV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-24-26 | Initiated | Barclays | Overweight |
| Jan-12-26 | Initiated | Guggenheim | Buy |
| Jan-09-26 | Initiated | Wells Fargo | Equal Weight |
| Oct-21-25 | Upgrade | Citigroup | Neutral → Buy |
| May-29-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jun-26-24 | Initiated | Piper Sandler | Neutral |
| Dec-13-22 | Downgrade | Citigroup | Buy → Neutral |
| Jul-12-22 | Initiated | Goldman | Neutral |
| Oct-04-21 | Resumed | Citigroup | Buy |
| Apr-07-21 | Initiated | B. Riley Securities | Buy |
| Mar-19-21 | Initiated | Barclays | Equal Weight |
View All
Claritev Corp Stock (CTEV) Latest News
Claritev Corp expected to post a loss of $4.01 a shareEarnings Preview - TradingView
How The Claritev (CTEV) Story Is Shifting As Analysts Trim Targets Yet Stay Positive - Yahoo Finance
CTEV SEC FilingsClaritev Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Claritev Cares Opens Rural Health Grants, Continuing Three Decades of Investment in Underserved Communities - The National Law Review
Earnings Preview: Claritev to Report Financial Results Pre-market on May 07 - 富途牛牛
Claritev Stockholders OK Directors, PwC and Pay Plan at 2026 Virtual Annual Meeting - MarketBeat
Claritev Corp (CTEV) director granted 8,977 restricted stock units in new award - Stock Titan
Claritev Corp (CTEV) director awarded 8,977 RSUs, updates indirect holdings - Stock Titan
Claritev Corp (CTEV) director receives 8,977 restricted stock units - Stock Titan
Claritev (CTEV) director granted 8,977 restricted stock units - Stock Titan
Claritev Corp (CTEV) director awarded 8,977 restricted stock units - Stock Titan
Claritev (CTEV) director receives 8,977 restricted stock units in grant - Stock Titan
Claritev (CTEV) director gets 8,977 RSUs with service-based vesting - Stock Titan
Claritev Shareholders Expand Incentive Plan, Back Board Slate - TipRanks
Claritev (NYSE: CTEV) investors approve incentive plan expansion and elect directors - Stock Titan
Claritev Chief AI Officer Fernando Schwartz Named to DataIQ 100 for Advancing AI-Driven Healthcare Performance - 01net
Claritev (CTEV) price target decreased by 26.64% to 66.10 - MSN
Claritev outlines 2026 revenue guidance of $980M–$1B as digital transformation accelerates - MSN
Claritev (NYSE:CTEV) Upgraded at Barclays - MarketBeat
Wall Street Zen Downgrades Claritev (NYSE:CTEV) to Sell - MarketBeat
CTEV Initiated Coverage by Barclays -- Rating Set to Overweight - GuruFocus
Claritev initiated with an Overweight at Barclays - TipRanks
Claritev (NYSE:CTEV) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Barclays Initiates Claritev(CTEV.US) With Buy Rating, Announces Target Price $28 - Moomoo
Barclays initiates Claritev stock with Overweight rating By Investing.com - Investing.com Australia
Barclays initiates Claritev stock with Overweight rating - Investing.com
Barclays initiates coverage of Claritev (CTEV) with overweight recommendation - MSN
CTEV (Claritev Corporation) shares rise nearly five percent despite posting a wider than expected Q4 2025 loss. - Xã Thanh Hà
CTEV Claritev Corporation reports wider than expected Q4 2025 loss, shares rise 4.8 percent amid bullish investor sentiment.Community Sell Signals - Cổng thông tin điện tử tỉnh Lào Cai
CTEV (Claritev) shares gain nearly 5 percent despite wider than expected Q4 2025 per share losses.Market Buzz Alerts - UBND thành phố Hải Phòng
Is Claritev (CTEV) stock a safe investment (Institutional Demand) 2026-04-22Stock Analysis Community - Cổng thông tin điện tử tỉnh Tây Ninh
Third Point Management Highlights Claritev Corporation Performance in Q1 2026 - HarianBasis.co
Concerns Surrounding AI Pressured Claritev Corp (CTEV) - Insider Monkey
Is Claritev (CTEV) stock maintaining its trend (Investor Interest) 2026-04-20Analyst Recommended Stocks - Cổng thông tin điện tử tỉnh Lào Cai
Claritev Corporation Announces First Quarter 2026 Earnings Conference Call - 01net
Press Release: Claritev Corporation Announces First Quarter 2026 Earnings Conference Call - Moomoo
Claritev: Compounding Debt Meets Legacy Business Stabilization (Rating Upgrade) (CTEV) - Seeking Alpha
How The Claritev (CTEV) Narrative Is Shifting As Targets Fall And Growth Plans Evolve - Yahoo Finance
Claritev Corporation (CTEV) Stock Analysis: Exploring a Potential 117% Upside in Healthcare Tech - DirectorsTalk Interviews
Claritev (CTEV) Stock Downtrend (Eye on Rally) 2026-04-15Viral Trade Signals - Cổng thông tin điện tử Tỉnh Sơn La
S P Trends: Is Claritev Corporation being accumulated by smart money2026 Final Week & Growth Focused Stock Pick Reports - baoquankhu1.vn
Aug Chart Watch: Is Claritev Corporation attractive at current valuation2026 Highlights & AI Powered Market Entry Strategies - baoquankhu1.vn
Citigroup Maintains Claritev (CTEV) Buy Recommendation - MSN
Is Claritev Corp (CTEV) a Bargain After 9.2% Drop? GF Value Says Undervalued - GuruFocus
TMA Joins MDL Against Claritev And Major Insurers - Hoodline
Texas Medical Association joins lawsuit alleging billions in underpayments by insurers - The Business Journals
Claritev (NYSE:CTEV) Shares Up 3.2%Still a Buy? - MarketBeat
Highs Report: Will Claritev Corporation benefit from seasonalityOptions Play & Technical Entry and Exit Tips - baoquankhu1.vn
Claritev Corp Stock (CTEV) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.66%
1.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):